JIA | |
---|---|
JIA patients, n | 121 |
Girls: Boys, n | 82:39 |
Caucasian: not Caucasian, n | 117:4 |
Age at enrolment (years) | 13.3 (11.3–15.1) |
Duration of MTX treatment (days) | 340 (142–766) |
MTXo: MTXSC, n | 45:76 |
MTX dose (mg/m2/week) | 9.7 (9.0–10.9) |
Patients with completed MISS, n | 120 |
MISS total score (0–36) | 8 (3–14) |
MTXintolerant subgroup1, n | 73 |
MTXtolerant subgroup, n | 47 |
Patients with ≥ 7 completed diary entries, n | 77 |
“MTX-nausea” subgroup2, n | 56 |